slide1
Download
Skip this Video
Download Presentation
Block Details : Total number of blocks received in RGCB –1004

Loading in 2 Seconds...

play fullscreen
1 / 14

Block Details : Total number of blocks received in RGCB –1004 - PowerPoint PPT Presentation


  • 110 Views
  • Uploaded on

Role of Human PapillomaVirus infection and other co factors in the aetiology of Head and Neck Cancer in Europe and India. Block Details : Total number of blocks received in RGCB –1004 Different sites from which we received the blocks are: Ambilikkai -148 Bangalore- 344 Guwahati-346

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Block Details : Total number of blocks received in RGCB –1004' - anja


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1
Role of Human PapillomaVirus infection and other co factors in the aetiology of Head and Neck Cancer in Europe and India
slide2

Block Details :

  • Total number of blocks received in RGCB –1004
  • Different sites from which we received the blocks are:
  • Ambilikkai -148
  • Bangalore- 344
  • Guwahati-346
  • Barshi-156
  • Trivandrum -10
slide3

Serum transferred to RGCB -540 (RCC, Trivandrum)

  • Total number of blocks sectioned -69
  • Blocks returned back to Bangalore after sectioning: 25
  • Blocks take n to IARC: Prospective-68(Ambilikkai), Retrospective-80(Ambilikkai)
  • Guwahati -40
  • Total : 188
  • Total number of shavings taken to IARC: 116 tubes and 13 boxes
slide4

Oral Saline washouts :

  • Pune: 320
  • Ambilikkai:216
  • Barshi: 341
  • DNA isolated: 877
slide5

Head and Neck Cancer is the 6th common malignancy reported worldwide with approximately 6,50000newcases and 3,50000 deaths are reported annually

  • Cancers of the head and neck include cancers of the oral cavity, larynx, pharynx, salivary glands and nasal passage
  • The prevalence of HPV in oral cavity, larynx and hypopharynxappears to be considerably lower
  • Oral cancer subtype of HNC(85%)
  • Several types of oral cancer ,around 90% squamous cell carcinoma originating in the tissue that line mouth and lips
slide6

Causative factors of oral cancer:

  • Alcohol abuse, radiation exposure, tobacco use, poor nutrition and poor hygiene
  • HPV is considered to be one of the factor
  • Symptoms include lump or sore that does not heal, difficulty in swallowing, change of hoarseness in the voice
slide7

Human papilloma virus:

  • Papillomaviridae family, double stranded DNA virus, infects cutaneous/mucosal surfaces
  • Infects basal layer of the skin
  • Genome: 8000basepairs, divided into 3 main domains a noncoding URR, an early region with ORF,and late region encoding capsid proteins
  • E6 and E7 binds to the tumor supressor gene pRb and p53
slide8

Objective of the study:

  • To address the crucial still unanswered questions on HNC aetiology with particular focus on the role of HPV infection
  • To determine whether HPV interact with additional HNC risk factors in Europe and Indian population
  • To know prevalence of DNA/RNApositivity in oral specimens and also to explore novel screening stratergies that could be broadly used in clinical routine
slide9

Materials and Methodology:

  • Total study size 2000 cases and 2000controls
  • Cases include cancers of the oral cavity , oropharynx, hypopharynx, and larynx
  • Samples include serum, oral saline wash and formalin fixed paraffin embedded tissue
slide10

Methodology:

  • Serology
  • Genotyping
  • Immunohistochemistry
  • Luminexxmap technology
slide11

Genotyping:

  • The process of determining difference in the genetic makeup of an individual by examining the individual DNA sequence using biological assays and comparing to another individual sequence for reference
  • Luminexxmap technology for detecting 19 high risk HPV types (16,18,26,31,33,35,39,45,51,52,53,56,58,59,66,68,70,73,82)and 2 low risk hpv types(6,11)
  • The assay includes Beta globin gene to evaluate the presence and quality of extracted DNA
slide12

Outline

  • Luminex® xMAP Technology
ad